Workshop 20 January 2025
List of people who will participate at workshop for convergence environments. Will be updated.
Microbiology and antimicrobial resistance
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Physical modelling of biological systems, Complex systems, Active matter, Biophysics |
||
Cancer immunotherapy, immunology, macrophages, T cells, tumor on chip, cell biology |
Development of novel strategies for cancer immunotherapy. T cell-based immunotherapies have revolutionized cancer treatment, but most patients with advanced cancer do not respond to current treatments or relapse. We propose to develop alternative strategies for cancer immunotherapy by taking advantage of other types of immune cells with anti-cancer activity such as macrophages. The ability of macrophages to eliminate invading bacteria may potentially be used to fight cancer, and vice versa. |
|
Bj?rn Dalhus |
Structural biology, molecular interactions, drug design, enzyme inhibitors, peptide drug design, molecular modeling. Cancer, antimicrobial resistance, neurodegenerative diseases, DNA repair. |
We have experiences in recombinant protein production and purification, protein stability and interaction studies. Several technologies for drug-target interaction studies, drug-target affinities, 3D modeling of molecular interactions and drug-target optimization. Of particular interest are cancer, antimicrobial resistance and neurodegenerative diseases. |
Susanne Dudman |
Antiviral resistance development, virus evolution, vaccine studies, One health |
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
Osman Gani |
Computer-aided drug design (CADD). Molecular Modeling |
|
Microbiology and antimicrobial resistance |
Resolving bacterial infections and reducing resistance targeting the host immune response |
|
vertebrate immunology, aquaculture |
Comparative studies of immune responses in mammals, fish and fish with evoutionary losses of immune genes important for function of the mammalian adaptive immune system (e.g. MHC class II locus lost in Atlantic cod). An emphasis on evolution of antibody responses in vaccinated (or infected) induviduals (i.e. days and weeks) as well as in evolutionary time (million years), by comparison between species. |
|
Dirk Linke |
bacteria-surface interactions |
novel antimicrobial apporaches that inhibit bacterial adhesion |
Reidar Lund |
- mechanisms of antimicrobial peptides |
Mechanism of action and encapsulation of antimicrobial peptides |
Ute Krengel |
Structural biology & infection biology |
Amyloids: Curse or Opportunity? – From Medicine to Cultural Heritage |
antimicrobial peptides, peptoids, drug delivery, self-assembly, structural characterization, antibiotics, antivirals, peptide-lipid interactions |
||
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
Resistome, microbiome, AMR |
This project idea is to focus on harnessing the potential of microbiota modulation to combat antimicrobial resistance (AMR) within the framework of the One Health approach. By leveraging interventions such as probiotics, prebiotics, and microbiome-targeted therapies, we aim to restore microbial balance and reduce the spread of resistant pathogens across humans, animals, and the environment. |
|
Simon Rayner |
Precision Health, Science and Society |
With the growth of misinformation, there is growing mistrust in science. I would like to integrate data from social media with metrics from scientific publications to investigate the interactions between science and society. For example, which scientific publications generate the most interest on social media? Which ones are associated with positive discussions?which ones are most misrepresented.?This would be a good opportunity for collaborations involving clinicians, life scientist and social sciences |
Molecular microbiology, Antimicrobial resistance, biofilms |
We are interested in understanding novel antimicrobial resistance mechanisms and resistance, selection and co-selection in a One Health perspective. We also try to identify inhibitors of resistance mechanisms and characterize how they work and can be used to mitigate the risks and consequences of AMR. |
|
Molecular immunology, adaptive immunity, cellular signaling, adaptor molecules, host-microbe interactions, intrinsically disordered proteins |
Biomolecular condensates in the machinery of life. Biomolecular condensates formed via phase separation is a newly appreciated and currently understudied phenomenon governing a wide range of cellular behaviour in health and disease. There is a need for novel theoretical and experimental approaches to adress the emerging properties of biomolecular condensates across multiple cell types and organisms. |
|
Antimicrobial resistance development, Microbial comparative and functional genomics, Microbial evolution, Bacterial virulence mechanisms |
UiO AMR - Cross-faculty AMR research initiative (LSB-CE) |
|
Systems brain health: Genetics, microbiome-host interaction; psychosocial stress; psychopathology; Machine Learning and modelling; Lifespan perspectives. |
I am interested in systems brain health which is under the influence of one's genetic composition, lifestyle choices and socioeconomic factors. The effects of the later two contributors can captured by the variation in one's commensal microbiota. To investigate this complex interactions I will take a lifespan perspective, by which the optimal window of intervention to prevent brain disorders can be uncovered. |
|
Molecular microbiology, antimicrobial resistance, vaccine development, One health, animal health. |
Antimicrobial resistance is one of the major global health threats. Our research groups is interested in approaching this problem on different ways from to understand basic biological mechanisms to drug use and new antimicrobial strategies. |
|
The machinery of life - molecular mechanisms and organism biology
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Physical modelling of biological systems, Complex systems, Active matter, Biophysics |
||
Melinka Butenko |
Signalling systems, toxins, structural biology, peptide activity, plant pathogen interactions. |
|
Advanced light microscopy, cell migration, tissue dynamics, biomechanics, active matter physics, developmental biology, tissue regeneration |
Bridging Active Matter Physics with Gene Regulation and Biological Evolution |
|
Cancer immunotherapy, immunology, macrophages, T cells, tumor on chip, cell biology |
Development of novel strategies for cancer immunotherapy. T cell-based immunotherapies have revolutionized cancer treatment, but most patients with advanced cancer do not respond to current treatments or relapse. We propose to develop alternative strategies for cancer immunotherapy by taking advantage of other types of immune cells with anti-cancer activity such as macrophages. The ability of macrophages to eliminate invading bacteria may potentially be used to fight cancer, and vice versa. |
|
Bj?rn Dalhus |
Structural biology, molecular interactions, drug design, enzyme inhibitors, peptide drug design, molecular modeling. Cancer, antimicrobial resistance, neurodegenerative diseases, DNA repair. |
We have experiences in recombinant protein production and purification, protein stability and interaction studies. Several technologies for drug-target interaction studies, drug-target affinities, 3D modeling of molecular interactions and drug-target optimization. Of particular interest are cancer, antimicrobial resistance and neurodegenerative diseases. |
mechanobiology, cellular and tissue motion, mechanics and dynamics, morphogenesis, sports physiology and biomechanics, novel imaging methods, traditional and AI-based image analysis, biosensor data collection and modeling. |
||
Lars Eide |
mitochondrial DNA dynamics, metabolism of branched-chain amino acids, bioenergetics, metabolic disease |
"adaptive metabolites"; e.g. amino acid (derivatives) with regulative properties throughout the phylogeny |
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
vertebrate immunology, aquaculture |
Comparative studies of immune responses in mammals, fish and fish with evoutionary losses of immune genes important for function of the mammalian adaptive immune system (e.g. MHC class II locus lost in Atlantic cod). An emphasis on evolution of antibody responses in vaccinated (or infected) induviduals (i.e. days and weeks) as well as in evolutionary time (million years), by comparison between species. |
|
Ute Krengel |
Structural biology & infection biology |
Amyloids: Curse or Opportunity? – From Medicine to Cultural Heritage |
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
Dirk Linke |
bacteria-surface interactions |
novel antimicrobial apporaches that inhibit bacterial adhesion |
Deo Pandey |
Cancer research, epigenetics and transcription, kinases and kinase inhibitors, drug discovery |
The aim is to advance our understanding of the molecular underpinnings of addiction and develop targeted therapies, addressing a critical and growing public health crisis with profound social and economic impacts. We will leverage advanced molecular biology techniques to identify and characterize shared molecular pathways, using drug screening and genetic approaches to pinpoint therapeutic targets. By integrating insights into cellular signaling, gene regulation, and pharmacological interventions, this collaborative effort seeks to drive the development of precision therapies for addiction disorders. |
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
bioinformatics, 3D genome organization, epigenetics, mechanobiology, gene transcription regulation |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
Simon Rayner |
Precision Health, Science and Society |
With the growth of misinformation, there is growing mistrust in science. I would like to integrate data from social media with metrics from scientific publications to investigate the interactions between science and society. For example, which scientific publications generate the most interest on social media? Which ones are associated with positive discussions?which ones are most misrepresented.?This would be a good opportunity for collaborations involving clinicians, life scientist and social sciences |
Gene expression, 3D genome and chromatin biology, epigenetics, cancer research, transcription factors |
||
Molecular microbiology, Antimicrobial resistance, biofilms |
We are interested in understanding novel antimicrobial resistance mechanisms and resistance, selection and co-selection in a One Health perspective. We also try to identify inhibitors of resistance mechanisms and characterize how they work and can be used to mitigate the risks and consequences of AMR. |
|
Molecular immunology, adaptive immunity, cellular signaling, adaptor molecules, host-microbe interactions, intrinsically disordered proteins |
Biomolecular condensates in the machinery of life. Biomolecular condensates formed via phase separation is a newly appreciated and currently understudied phenomenon governing a wide range of cellular behaviour in health and disease. There is a need for novel theoretical and experimental approaches to adress the emerging properties of biomolecular condensates across multiple cell types and organisms. |
|
Molecular microbiology, antimicrobial resistance, vaccine development, One health, animal health. |
Antimicrobial resistance is one of the major global health threats. Our research groups is interested in approaching this problem on different ways from to understand basic biological mechanisms to drug use and new antimicrobial strategies. |
|
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
Digital life science
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Physical modelling of biological systems, Complex systems, Active matter, Biophysics |
||
Digital life skills, digital life skills education, digital life skills and language education. Classroom studies in several school subjects. |
||
Advanced light microscopy, cell migration, tissue dynamics, biomechanics, active matter physics, developmental biology, tissue regeneration |
Bridging Active Matter Physics with Gene Regulation and Biological Evolution |
|
Cancer immunotherapy, immunology, macrophages, T cells, tumor on chip, cell biology |
Development of novel strategies for cancer immunotherapy. T cell-based immunotherapies have revolutionized cancer treatment, but most patients with advanced cancer do not respond to current treatments or relapse. We propose to develop alternative strategies for cancer immunotherapy by taking advantage of other types of immune cells with anti-cancer activity such as macrophages. The ability of macrophages to eliminate invading bacteria may potentially be used to fight cancer, and vice versa. |
|
mechanobiology, cellular and tissue motion, mechanics and dynamics, morphogenesis, sports physiology and biomechanics, novel imaging methods, traditional and AI-based image analysis, biosensor data collection and modeling. |
||
Thomas Espeseth |
Learning and memory as life processes, Cognition and brain-inspired artificial intelligence, AI explainability, Ethical AI and societal impact |
The aim is to explore the intersection of cognitive neuroscience, AI, and societal impact by investigating how cognitive and brain data can inform and enhance artificial intelligence systems designed to support learning and communication, while also advancing scientific understanding of cognitive processes. |
Osman Gani |
Computer-aided drug design (CADD). Molecular Modeling |
|
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
Digital life skills and digital life skills education, digital citizenship education. |
Digital life skills and digital life skills education, digital citizenship in education. Classroom studies in several school subjects. |
|
computational biology, gene expression regulation, multi-omics, machine learning, AI, transcription factors |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
bioinformatics, 3D genome organization, epigenetics, mechanobiology, gene transcription regulation |
With an integrated computational approach, we will provide insight into the interactions between fundamental biological processes in gene expression across domains and in health and disease. |
|
Simon Rayner |
Precision Health, Science and Society |
With the growth of misinformation, there is growing mistrust in science. I would like to integrate data from social media with metrics from scientific publications to investigate the interactions between science and society. For example, which scientific publications generate the most interest on social media? Which ones are associated with positive discussions?which ones are most misrepresented.?This would be a good opportunity for collaborations involving clinicians, life scientist and social sciences |
bioinformatics, computational biology, gene expression, health and disease |
Use computational approaches to unravel the interplay between the different layers involved in gene expression. |
|
Molecular immunology, adaptive immunity, cellular signaling, adaptor molecules, host-microbe interactions, intrinsically disordered proteins |
Biomolecular condensates in the machinery of life. Biomolecular condensates formed via phase separation is a newly appreciated and currently understudied phenomenon governing a wide range of cellular behaviour in health and disease. There is a need for novel theoretical and experimental approaches to adress the emerging properties of biomolecular condensates across multiple cell types and organisms. |
|
J?rgen Sugar |
Neuroscience, Memory |
Attention is important for memory. How is attention formed in the brain and how is it used to successfully form memories? My idea is to record neural data in humans while they perform a memory task that is highly dependent on attention. |
Neuroscience, microscopy, in vivo cellular imaging, mouse behavior and psychophysics, computational statistics, optogenetics, eye tracking, olfaction, visual and auditory physiology, learning and memory, Alzheimer's disease, brain tumours, sleep. |
||
Systems brain health: Genetics, microbiome-host interaction; psychosocial stress; psychopathology; Machine Learning and modelling; Lifespan perspectives. |
I am interested in systems brain health which is under the influence of one's genetic composition, lifestyle choices and socioeconomic factors. The effects of the later two contributors can captured by the variation in one's commensal microbiota. To investigate this complex interactions I will take a lifespan perspective, by which the optimal window of intervention to prevent brain disorders can be uncovered. |
|
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
Rein Aasland |
bioinformatics, bioinformatics data, gene expression, gene regulation, chromosomes, epigenetics, evolution |
Use bioinformatics to how explore gene expression influences development and disease |
Bioethics
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|
Physical modelling of biological systems, Complex systems, Active matter, Biophysics |
||
Cancer immunotherapy, immunology, macrophages, T cells, tumor on chip, cell biology |
Development of novel strategies for cancer immunotherapy. T cell-based immunotherapies have revolutionized cancer treatment, but most patients with advanced cancer do not respond to current treatments or relapse. We propose to develop alternative strategies for cancer immunotherapy by taking advantage of other types of immune cells with anti-cancer activity such as macrophages. The ability of macrophages to eliminate invading bacteria may potentially be used to fight cancer, and vice versa. |
|
Mathematical modeling, knowledge-driven machine learning, digital twins, personalized cancer therapies, biomarkers, genomics, medical imaging. |
Personalized cancer therapy integrating multi-type clinical data, biological experimentation, mechanistic mathematical models and artificial intelligence. |
|
John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
Statistical learning/ machine learning (ML) and AI for translational and clinical cancer research, in particular for personalised cancer therapies. Integration of data from diverse sources (multi-omics, drug screens, clinical, imaging, genomics) for prediction of drug response and synergies in pharmacogenomic screens and of prognosis and treatment response in patients. Machine learning for small and noisy (biomedical) data, e.g. through integration of knowledge and structure in ML. |
AI and robotics for personalised cancer medicine: Next-generation pipelines and tools for overcoming drug resistance in cancer by studying the full dynamics and evolution of the tumor and its environment in large-scale screens, in vitro, in vivo and in silico. |
|
No specified topic
Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
---|---|---|